These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10458518)

  • 1. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
    Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
    Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Gergen KA; Chang SL; Niu YF; Kastin AJ; Zadina JE
    Peptides; 1994; 15(8):1505-11. PubMed ID: 7700853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
    Zadina JE; Kastin AJ; Hackler L; Chang SL
    Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A; Dzambazova-Maximova E
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid and antiopioid actions of Tyr-MIF-1, Tyr-W-MIF-1 and hemorphin-4 on rat locus coeruleus neurons: intracellular recording in vitro.
    Yang YR; Chiu TH
    Chin J Physiol; 1997 Sep; 40(3):131-5. PubMed ID: 9434888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picrotoxin-induced seizures modified by morphine and opiate antagonists.
    Thomas J; Nores WL; Kenigs V; Olson GA; Olson RD
    Pharmacol Biochem Behav; 1993 Jul; 45(3):615-7. PubMed ID: 8101378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
    Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells.
    Harrison LM; Kastin AJ; Zadina JE
    J Pharmacol Exp Ther; 1998 Feb; 284(2):611-7. PubMed ID: 9454805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.